Cumulative Rates of Serious and Adverse Events of Special Interest in Vaccinees Following AZD1222 (ChAdOx1 nCoV-19): Results from a UK Post-authorisation Active Surveillance Study

被引：0
|
作者：
Evans, Alison [1 ]
Roy, Debabrata [1 ]
Davies, Miranda [1 ]
Dhanda, Sandeep [1 ]
Shakir, Saad [1 ]
机构：
[1] Drug Safety Res Unit, Southampton, Hants, England
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1528
引用
收藏
页码：693 / 693
页数：1
相关论文
共 40 条
  • [21] Dynamics of anti-RBD (anti-receptor binding domain) levels in diabetes patients following the ChAdOx1 nCoV-19 vaccine (AZD1222) in the Thai population
    Supamas Sirisreetreerux
    Thachanun Porntharukchareon
    Bothamai Dechates
    Vimonsri Rangsrisaeneepitak
    Phonthip Therawit
    Supanat Worawitchawong
    Gaidganok Sornsamdang
    Kamonwan Soonklang
    Kriangkrai Tawinprai
    Scientific Reports, 13 (1)
  • [22] Dynamics of anti-RBD (anti-receptor binding domain) levels in diabetes patients following the ChAdOx1 nCoV-19 vaccine (AZD1222) in the Thai population
    Sirisreetreerux, Supamas
    Porntharukchareon, Thachanun
    Dechates, Bothamai
    Rangsrisaeneepitak, Vimonsri
    Therawit, Phonthip
    Worawitchawong, Supanat
    Sornsamdang, Gaidganok
    Soonklang, Kamonwan
    Tawinprai, Kriangkrai
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [23] Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A risk-benefit analysis for people < 60 years in Australia
    MacIntyre, Chandini Raina
    Veness, Benjamin
    Berger, David
    Hamad, Nada
    Bari, Noor
    VACCINE, 2021, 39 (34) : 4784 - 4787
  • [24] Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study
    Carl H. Göbel
    Axel Heinze
    Sarah Karstedt
    Mascha Morscheck
    Lilian Tashiro
    Anna Cirkel
    Qutyaba Hamid
    Rabih Halwani
    Mohamad-Hani Temsah
    Malte Ziemann
    Siegfried Görg
    Thomas Münte
    Hartmut Göbel
    Pain and Therapy, 2021, 10 : 1309 - 1330
  • [25] Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study
    Goebel, Carl H.
    Heinze, Axel
    Karstedt, Sarah
    Morscheck, Mascha
    Tashiro, Lilian
    Cirkel, Anna
    Hamid, Qutyaba
    Halwani, Rabih
    Temsah, Mohamad-Hani
    Ziemann, Malte
    Goerg, Siegfried
    Muente, Thomas
    Goebel, Hartmut
    PAIN AND THERAPY, 2021, 10 (02) : 1309 - 1330
  • [26] Serious events following COVID-19 vaccination with ChAdOx1 nCoV-19 vaccine (Vaxzevria) : A short case series from Iran
    Khajavirad, Nasim
    Salehi, Mohammadreza
    Ghadery, Abdolkarim Haji
    Khalili, Hossein
    Ahmadi, Mehran Arab
    Manshadi, Seyed Ali Dehghan
    Dehnavi, Ali Zare
    CLINICAL CASE REPORTS, 2022, 10 (02):
  • [27] Active Symptom-Based Surveillance of Adverse Events Following Immunization Among Individuals Vaccinated with ChAdOx1 nCoV-19 Coronavirus Vaccine in a Tertiary Hospital of Kerala
    Jose, Maria
    Rajmohan, Priyanka
    Thomas, Joe
    Krishna, Swathi
    Antony, Beena
    Gopinathan, Unnikrishnan U.
    Iyyapan, Elsy M.
    Porinchu, Raphael M.
    Jose, Ponnu
    Raphael, Lucy
    Kuttichira, Praveenlal
    CURRENT DRUG SAFETY, 2022, 17 (04) : 327 - 334
  • [28] Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
    Voysey, Merryn
    Clemens, Sue Ann Costa
    Madhi, Shabir A.
    Weckx, Lily Y.
    Folegatti, Pedro M.
    Aley, Parvinder K.
    Angus, Brian
    Baillie, Vicky L.
    Barnabas, Shaun L.
    Bhorat, Qasim E.
    Bibi, Sagida
    Briner, Carmen
    Cicconi, Paola
    Collins, Andrea M.
    Colin-Jones, Rachel
    Cutland, Clare L.
    Darton, Thomas C.
    Dheda, Keertan
    Duncan, Christopher J. A.
    Emary, Katherine R. W.
    Ewer, Katie J.
    Fairlie, Lee
    Faust, Saul N.
    Feng, Shuo
    Ferreira, Daniela M.
    Finn, Adam
    Goodman, Anna L.
    Green, Catherine M.
    Green, Christopher A.
    Heath, Paul T.
    Hill, Catherine
    Hill, Helen
    Hirsch, Ian
    Hodgson, Susanne H. C.
    Izu, Alane
    Jackson, Susan
    Jenkin, Daniel
    Joe, Carina C. D.
    Kerridge, Simon
    Koen, Anthonet
    Kwatra, Gaurav
    Lazarus, Rajeka
    Lawrie, Alison M.
    Lelliott, Alice
    Libri, Vincenzo
    Lillie, Patrick J.
    Mallory, Raburn
    Mendes, Ana V. A.
    Milan, Eveline P.
    Minassian, Angela M.
    LANCET, 2021, 397 (10269): : 99 - 111
  • [29] Adverse events following introduction of the ChAdOx1 nCoV-19 vaccine in Somalia in 2021: findings from a fragile setting and implications for the future
    Hamayoun, Mohammad
    Abdulrazak, Ibrahim
    Farid, Muhammad
    Malik, Mamunur Rahman
    Farah, Mohammed
    IJID REGIONS, 2022, 4 : 47 - 52
  • [30] Adverse events following immunization with ChAdOx1 nCoV-19 and BBIBP-CorV vaccine: A comparative study among healthcare professionals of Nepal
    Rayamajhi, Sushil
    Rafi, Md. Abdur
    Tripathi, Nishant
    Dongol, Anjana Singh
    Pandey, Minalma
    Rayamajhi, Shreejana
    Bhandari, Subhechchha
    Shrestha, Pranay
    Hasan, M. Tasdik
    Hossain, Md. Golam
    PLOS ONE, 2022, 17 (08):
1234